Results 211 to 220 of about 9,342,565 (376)

Cord-Blood Engraftment Using an Enhanced Dual-Conditioning Regimen for Malignant Hematologic Diseases. [PDF]

Cell Transplant, 2022
Ding J, Fang Y, Zhou R, Gu Y, Du S, Lu Q, Yue Q.   +6 more
europepmc   +1 more source

Distribution of JC Virus DNA in Peripheral Blood Lymphocytes of Hematological Disease Cases.

, 1999
N Shimizu, Akira Imamura, Osami Daimaru, Hidetsugu Mihara, Yoshiro Kato, Ryoichi Kato, Takashi Oguri, Masako Fukada, Takashi Yokochi, Kazuhiro Yoshikawa, Hirokazu Komatsu, Ryuzo Ueda, Masakazu Nitta   +12 more
openalex   +2 more sources

Localized Delivery of the mRNAs Encoding CD47 Inhibitor and Interleukins 12, 15, and 21 Elicits Robust Antitumor Immunity

Advanced Science, EarlyView.
The co‐delivery of mRNAs encoding a CD47 inhibitor and a cytokine cocktail (interleukins 12, 15, and 21) via lipid nanoparticles enables effective localized immunotherapy. This strategy not only suppresses tumor progression but also enhances type 1 conventional dendritic cell (cDC1) differentiation and activates CD8+ T cells, thereby inducing robust ...
Tao Jiang, Shuaiyang Jing, Haojun Li, Bao Xiao, Jiahui Jin, Xiu Sun, Juan Wang, Jing Liang, Tongze Cai, Huili Hu, Meilan Wei, Xuanrui Zhong, Yang Ji, Peng George Wang, Jianlong Zhou   +14 more
wiley   +1 more source

Minimal Residual Disease in Hematological Malignancies [PDF]

, 2004
Pia Raanani, Andreas Hochhaus
openalex   +1 more source

HERV‐K TM Subunit Elicits CD8+ T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC

Advanced Science, EarlyView.
Novel viral immune checkpoint K‐TM subunit is aberrantly expressed in CD8+ T cells and enriched in sera of cancer patients, inducing CD8+ T cell anergy and eliciting potent tumor immune escape in mouse model. Mechanistically, K‐TM directly targets and induces the phosphorylation of CD3ε receptor.
Mengyuan Li, Shuwen Zheng, Qinyuan Gong, Zhaoxing Wu, Wen Lei, Wanyue Cao, Ping Wang, Xuzhao Zhang, Wenbin Qian, Yun Liang, Ying Lu, Fenglin Li, Qi Zhang, Rongzhen Xu   +13 more
wiley   +1 more source

The role of the pulmonary function laboratory in the management of hematologic diseases. [PDF]

J Bras Pneumol
Neder JA, O'Donnell DE, Berton DC.
europepmc   +1 more source

Clinical, Biochemical, and Hematological Characteristics, Disease Prevalence, and Prognosis of Dogs Presenting with Neutrophil Cytoplasmic Toxicity [PDF]

, 2005
Itamar Aroch, Eyal Klement, Gilad Segev
openalex   +1 more source

In Situ Proliferating Peptide Nanoparticle Augments Multi‐Target Intervention of Secondary Brain Damage Following Subarachnoid Hemorrhage

Advanced Science, EarlyView.
This work designs an in situ proliferating peptide nanoparticle as a flexible resolution that modulates the neuro‐glia unit to enable enhanced multi‐target combinational therapy for secondary brain damage following subarachnoid hemorrhage. Abstract Subarachnoid hemorrhage (SAH), a lethal stroke subtype, involves complex pathological cascades triggered ...
Yibin Zhang, Peisen Yao, Fuxiang Chen, Shufa Zheng, Xuegang Niu, Haojie Wang, Yuanxiang Lin, Bin Gao, Dezhi Kang   +8 more
wiley   +1 more source

Clinical Value of Tocilizumab in Reducing Mortality in Refractory Septic Shock in Children with Hematologic and Non-Hematologic Diseases. [PDF]

Cells
Lee EP, Lin JJ, Chen SH, Chan OW, Su YT, Hsiao MR, Hsia SH, Wu HP.   +7 more
europepmc   +1 more source

Safety of rehabilitation interventions for patients with hematologic diseases associated with low blood counts-verification focusing on blood cancer. [PDF]

J Phys Ther Sci, 2021
Moriyama T, Takami A, Makino M.
europepmc   +1 more source